↗8 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$1.4MSold on the market
1Companies
Oct 21, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 202617:17 | Oct 20, 2026 | ORICOric Pharmaceuticals, Inc. | Chief Financial Officer | S · Sell10b5-1 | $13.53 | −14,000 | 69,828 | -17% | −$189K | ||
| Oct 21, 202617:17 | Oct 20, 2026 | ORICOric Pharmaceuticals, Inc. | Chief Financial Officer | M · Exercise10b5-1 | $4.36 | +14,000 | 83,828 | +20% | $61K | ||
| Sep 29, 202619:16 | Sep 28, 2026 | ORICOric Pharmaceuticals, Inc. | Chief Financial Officer | S · Sell10b5-1 | $13.53 | −13,400 | 69,828 | -16% | −$181K | ||
| Sep 29, 202619:16 | Sep 28, 2026 | ORICOric Pharmaceuticals, Inc. | Chief Financial Officer | M · Exercise10b5-1 | $4.36 | +13,400 | 83,228 | +19% | $58K | ||
| Sep 25, 202619:59 | Sep 24, 2026 | ORICOric Pharmaceuticals, Inc. | Chief Financial Officer | S · Sell10b5-1 | $13.50 | −600 | 69,828 | -1% | −$8K | ||
| Sep 25, 202619:59 | Sep 24, 2026 | ORICOric Pharmaceuticals, Inc. | Chief Financial Officer | M · Exercise10b5-1 | $4.36 | +600 | 70,428 | +1% | $3K | ||
| Aug 28, 202616:11 | Aug 26, 2026 | ORICOric Pharmaceuticals, Inc. | Chief Financial Officer | S · Sell10b5-1 | $13.69 | −77,000 | 69,828 | -52% | −$1.1M | ||
| Aug 28, 202616:11 | Aug 26, 2026 | ORICOric Pharmaceuticals, Inc. | Chief Financial Officer | M · Exercise10b5-1 | $4.89 | +77,000 | 146,828 | +110% | $377K |